✦ LIBER ✦

Characterization of a Novel, Potent and Selective Small Molecule Spleen Tyrosine Kinase (SYK) Inhibitor in In Vitro and In Vivo Models of Asthma.

✍ Scribed by Crackower, M.A.; Moy, L.Y.; Jia, Y.; Yu, H.; Vincent, S.; Miller, J.R.; Lieber, G.; Fernandez, X.; Caniga, M.; Gil, M.; Wilhelm, A.; Houshyar, H.; Northrup, A.; Chapman, R.; Abraham, W.M.; Kelly, N.; Hickey, E.; Miller, T.

Book ID: 119286459
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 44 KB
Volume: 129
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2011.12.846

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo characterization of

In vitro and in vivo characterization of a potent tyrosine kinase inhibitor that modulates angiogenesis and cancer cell proliferation

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 267 KB

A Novel Small-Molecule Inhibitor of Prot

A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo

✍ Harikumar, K. B.; Kunnumakkara, A. B.; Ochi, N.; Tong, Z.; Deorukhkar, A.; Sung, 📂 Article 📅 2010 🏛 American Association for Cancer Research 🌐 English ⚖ 724 KB

YN968D1 is a novel and selective inhibit

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

YN968D1 is a novel and selective inhibit

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo

✍ Shu Tian; Haitian Quan; Chengying Xie; Haiyi Guo; Fangfang Lü; Yongping Xu; Jin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Angiogenesis is an important process in cell development, especially in cancer. Vascular endothelial growth factor (VEGF) signaling is an important regulator of angiogenesis. Several therapies that act against VEGF signal transduction have been developed, including YN968D1, which is a potent inhibit

VX-680, a potent and selective small-mol

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

✍ Harrington, Elizabeth A; Bebbington, David; Moore, Jeff; Rasmussen, Richele K; A 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 594 KB

In vitro and in vivo characterization of

In vitro and in vivo characterization of SGI-1252, a small molecule inhibitor of JAK2

✍ Kausar Begam Riaz Ahmed; Steven L. Warner; Andrew Chen; Eric S. Gourley; Xiaohui 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 965 KB